链球菌抗癌制剂OK-432（NSC-B116209）的临床经验 - Suppr

Suppr

超能文献

Clinical experiences with the streptococcal anticancer preparation, OK-432 (NSC-B116209).

作者信息

Kurokawa T, Hattori T, Furue H

出版信息

Cancer Chemother Rep. 1972 Apr;56(2):211-20.

PMID:4557736

Abstract

摘要

相似文献

Clinical experiences with the streptococcal anticancer preparation, OK-432 (NSC-B116209).

Cancer Chemother Rep. 1972 Apr;56(2):211-20.

Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

Cancer Chemother Rep. 1972 Feb;56(1):9-17.

[Effect of streptococcal preparation "PC-B-45" on malignant head and neck tumors].

Nihon Jibiinkoka Gakkai Kaiho. 1969 Aug;72(8):1332-8.

Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent.

Cancer Chemother Rep. 1972 Apr;56(2):221-7.

Experimental and clinical studies on the antitumor activity of a streptococcal preparation (OK-432).

Jpn J Exp Med. 1974 Oct;44(5):399-411.

[Results of clinical study of the antineoplastic antibiotic rubomycin].

Antibiotiki. 1968 Sep;13(9):846-50.

[Anticancer chemotherapy with rubidomycin (preliminary note on 14 cases].

Pathol Biol. 1967 Oct;15(19):969-70.

[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors].

Schweiz Med Wochenschr. 1972 Aug 26;102(34):1213-21.

[Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].

Antibiotiki. 1967 Jul;12(7):609-19.

[Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].

Antibiotiki. 1972 Aug;17(8):675-80.

引用本文的文献

Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective - A retrospective case series.

Ann Med Surg (Lond). 2022 Sep 2;81:104531. doi: 10.1016/j.amsu.2022.104531. eCollection 2022 Sep.

Intrauterine therapy for macrocystic congenital cystic adenomatoid malformation of the lung.

Obstet Gynecol Sci. 2014 Mar;57(2):102-8. doi: 10.5468/ogs.2014.57.2.102. Epub 2014 Mar 15.

Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.

J Clin Immunol. 1981 Jul;1(3):154-62. doi: 10.1007/BF00922757.

Clinical studies on streptococcal preparation (OK-432) combined with mitomycin-C, 5-FU and cytosine arabinoside in advanced cancer patients.

Jpn J Surg. 1975 Sep;5(3):133-8. doi: 10.1007/BF02469393.

Treatment of gastric cancer, with special reference to the survivals of the cancer patients treated with multiple combination MFC therapy or immunochemotherapy of MFC plus OK-432 (NSC B116209).

Gastroenterol Jpn. 1977;12(2):20-9. doi: 10.1007/BF02773621.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验